FibroGen Inc (FGEN) — Capital Reinvestment Ratio

Latest as of June 2025: 0.00x

FibroGen Inc (FGEN) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($12.68 Million) in capital expenditures ($13.00K). Check FibroGen Inc (FGEN) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$12.68 Million
USD

Capital Expenditures

$13.00K
USD

Data as of

Jun 2025
Most recent filing

FibroGen Inc Capital Reinvestment Ratio (2013–2020)

This chart tracks FibroGen Inc's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does FibroGen Inc generate cash.

Annual Capital Reinvestment Ratio for FibroGen Inc (2013–2020)

Year-by-year Capital Reinvestment Ratio for FibroGen Inc from 2013 to 2020. See FGEN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2020 0.05x $81.60 Million $3.99 Million ▼ -72.2%
2016 0.18x $7.11 Million $1.25 Million ▼ -51.4%
2014 0.36x $22.41 Million $8.12 Million ▲ +37.9%
2013 0.26x $25.92 Million $6.81 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow